A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

PHASE4CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
DyslipidemiasCardiovascular DiseasesHypertriglyceridemia
Interventions
DRUG

fenofibrate

Fenofibrate Capsule 200mg qd orally

Trial Locations (1)

36100

Site Reference ID/Investigator# 64695, Xiamen

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Rundo International Pharmaceutical Research & Development Co.,Ltd.

INDUSTRY

lead

Abbott

INDUSTRY